Conmed (CNMD) Amortizatization of Intangibles (2010 - 2021)
Conmed (CNMD) posted Amortizatization of Intangibles of $2.6 million for Q4 2021, little changed on a QoQ basis from $2.6 million in Q3 2021, and up 6.24% year-over-year from $2.5 million in Q4 2020.
Conmed (CNMD) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
Conmed's Amortizatization of Intangibles history runs 12 years deep, the most recent figure standing at $2.6 million for Q4 2021.
- Quarterly Amortizatization of Intangibles rose 6.24% year-over-year to $2.6 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $2.6 million (down 74.09% YoY) and the FY2021 annual result came in at $10.2 million, up 5.42% from the prior year.
- Amortizatization of Intangibles was $2.6 million for Q4 2021 at Conmed, roughly flat from $2.6 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $21.5 million in Q2 2018 and bottomed at -$32.3 million in Q4 2018.
- A 5-year average of $1.5 million and a median of $2.5 million in 2020 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2017 — Amortizatization of Intangibles slumped 416.73% — and 2018, when it jumped 129.03%.
- Conmed's Amortizatization of Intangibles stood at -$28.1 million in 2017, then dropped by 15.18% to -$32.3 million in 2018, then jumped by 107.0% to $2.3 million in 2019, then gained by 8.35% to $2.5 million in 2020, then rose by 6.24% to $2.6 million in 2021.
- Business Quant data shows CNMD's Amortizatization of Intangibles at $2.6 million in Q4 2021, $2.6 million in Q3 2021, and $2.5 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.61 Mn |
| Dec 31, 2021 | 2.61 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 2.45 Mn |
| Dec 31, 2020 | 2.45 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 2.50 Mn |
| Jun 30, 2020 | 2.50 Mn |
| Mar 31, 2020 | 2.26 Mn |
| Mar 31, 2020 | 2.26 Mn |
| Dec 31, 2019 | 2.26 Mn |
| Dec 31, 2019 | 2.26 Mn |
| Sep 30, 2019 | 2.30 Mn |
| Sep 30, 2019 | 2.30 Mn |